Saira Ramasastry, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 5,000 shares at $25.68 ($128K) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Scheduled sale ($128k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2026-04-16 | $194K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $182K | — | Filing → |
| MIRM | SELL | 2026-02-17 | $204K | — | Filing → |